Opiod lawsuits and Congress hates them. Probably gonna double bottom here. Just an idea, no position because I'm already short on a few things.
Since breaking-out last October'18, ACASTI PHARMA INC - NASDAQ:ACST has been trading in a side-ways grind with no real progress towards higher levels to speak of. However, we've been monitoring the action closely for some time now and it appears that ACST may just be starting to pick its head up as evidenced in the Daily chart above. With the stock trading...
After breaking-out in early Spring (March), APELLIS PHARMACEUTICALS INC - NASDAQ:APLS has been building-out its right side in a prolonged base and presently finds itself nearing a potential move that may just catapult the stock into higher ground as evidenced in the Daily chart above. While further work is required, APLS presently trades above all of its...
After breaking to higher ground in 1Q19 and subsequently drifting back down to its original break-out level in the upper teen's, the shares of AMARIN CORP NASDAQ: AMRN are once again starting to show signs of potentially setting-up for another attempt at loftier levels as evidenced in the Daily chart above. While AMRN presently finds itself in drift mode...
Today we gonna look at the pharmaceutical company, as a potential new giant trend on the stock market. NASDAQ:BMRN laying on the strong support line near $87.87 and can move up suddenly. My recommendation: 1. Buy now around 87.87 2. Take profit: 109.45 3. SL: 78.68 Risk/Reward - 2.39, potential profit - 24,6%
Another pharma company - with amazing correct Elliot 5 waves which you can try to ride. 1. Buy 131.32 2. Take profit: 213 3. SL: 115.90 RISK/REWARD: 5.38, potential profit 62.39%
Pieris Pharmaceuticals is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. The company's clinical pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, inhaled Anticalin proteins to treat respiratory diseases,...
Zynerba crashed into resistance at at $16.50 on May 17th 2019, and went into correction territory. The engulfing candlestick today May 29th, 2019 is a very bullish sign ZYNE could go up to at least the $16.50 line. Technicals are not great, however I expect them to start confirming the bullish trend soon. Recommended trade: Long: $13.15 (20SMA) Sell-target:...
Bought at 1.86p & 1.74p today. Company turning around with new CEO & new plans moving ahead. Amazing tech with a huge amount of potential. Cash in bank with last placing a month ago at 1.6p so plenty of time to grow.
chart doesn't look good until we move through/ hold above ICHI cloud
volume spike today on no news, looking rather strong if close above 20ma this week. looks like it's breaking the down trend. 17p 1st target 23.6p 2nd target area
Perfect setup forming for a good short opp from $5.00 - $3.25
practice either way, long on it
Chart is in a range at moment with over 4.39p will be a breakout. I would look for 2.7p for a potential entry / scale in if keen on the company look for a retouch of the t-line. at times it is best to start scaling in ahead of support in case u miss it
target 1: $3.70 - 3.94 lets see how the next 2 weeks play out (some time around 4/24/2019)
Here we can see the beginning of a large sequence to the downside in many cannabis stocks. I am going short across the board here as the sector looks very soft and recommending all to write upside volatility or simply short the common stock for infinity. From a technical perspective we are struggling at heavy resistance and beginning a new sequence to the...
Really like this chart & can see a good rise after MM's pull price down to support at 74.4p - also 200ma weekly at 72p Best to scale in near the support level but watch out if RSI support level is not respected or 200ma as well, be ready to move out if so.